Additional information
| Active substance | Trastuzumab |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | HER2 testing (immunohistochemistry or fluorescence in situ hybridization) |
| Also known as | rhuMAb HER2 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause hypertension |
| Trade name | Herceptin |
| Storage conditions | Store refrigerated at 2-8В°C (36-46В°F) |
| Chemical name | Trastuzumab |
| Formula | C6484H9996N1720O2014S44 |
| Substance class | Monoclonal antibody |
| Main action | HER2/neu receptor antagonist |
| Half-life | Approximately 28 days |
| Dosage (medical) | Typically 4 mg/kg as a loading dose followed by 2 mg/kg weekly or 6 mg/kg every three weeks |
| Dosage (sports) | Not applicable |
| Effects | Reduction in tumor growth, improved survival in breast cancer patients |
| Side effects | Fever, nausea, vomiting, infusion reactions, cardiotoxicity |
| Use in sports | None |
| Manufacturer | Roche |
AVELOX 400 Bayer
LACIPIL 4 mg Glaxosmithkline
Zyban Glaxosmithkline
Champix 56 tabs Pfizer
Balkan Pharma Turanabol 10 mg 60 Tabletten
Balkan Pharma Danabol 50 mg 60 Tabletten
Zimaks 400 Bilim
Prograf 1mg Astellas Pharma
Champix Starter Pack Pfizer
Seretide Disckus (Advair) 500 mcg Glaxosmithkline 

Reviews
There are no reviews yet.